| Literature DB >> 31230945 |
Weifeng Liu1, Sarah C Garrett1, Elena V Fedorov1, Udupi A Ramagopal1, Scott J Garforth1, Jeffrey B Bonanno1, Steven C Almo2.
Abstract
CD160 is a signaling molecule that interacts with herpes virus entry mediator (HVEM) and contributes to a wide range of immune responses, including T cell inhibition, natural killer cell activation, and mucosal immunity. GPI-anchored and transmembrane isoforms of CD160 share the same ectodomain responsible for HVEM engagement, which leads to bidirectional signaling. Despite the importance of the CD160:HVEM signaling axis and its therapeutic relevance, the structural and mechanistic basis underlying CD160-HVEM engagement has not been described. We report the crystal structures of the human CD160 extracellular domain and its complex with human HVEM. CD160 adopts a unique variation of the immunoglobulin fold and exists as a monomer in solution. The CD160:HVEM assembly exhibits a 1:1 stoichiometry and a binding interface similar to that observed in the BTLA:HVEM complex. Our work reveals the chemical and physical determinants underlying CD160:HVEM recognition and initiation of associated signaling processes.Entities:
Keywords: CD160 and HVEM; IgSF and TNFRSF interactions; Interaction promiscuity; T cell costimulation and coinhibition; X-ray structures; immune regulation; intermolecular beta-sheet
Mesh:
Substances:
Year: 2019 PMID: 31230945 PMCID: PMC7477951 DOI: 10.1016/j.str.2019.05.010
Source DB: PubMed Journal: Structure ISSN: 0969-2126 Impact factor: 5.006